ebook: Accelerate vaccine development
Posted: 13 May 2021 | Molecular Devices | No comments yet
Our comprehensive portfolio suite is designed to optimize your productivity to get safe and efficacious vaccines and therapeutics to market faster.
Immunology is now, more than anytime in recent history, one of the top fields of research. With antibody-drug conjugate and bispecific antibody products recently reaching the market, the use of mAbs will remain a key part of therapeutic development.
Learn more about:
- Automated screening & selection of high-expressing cell lines
- Novel antibody internalization and binding assays
- Easy expression assays
- Objective verification of monoclonalit
Related content from this organisation
- High-throughput 3D cell migration assays in organ-on-a-chip technologies
- Application note: GxP regulated industry assessments of SoftMax Pro Software and microplate readers
- Video: Empower your electrophysiology studies using new Axon pCLAMP 11 software
- On-demand webinar: An AI-based approach to phenotypic characterisation of neuronal cells
- Application note: High-content phenotypic profiling using the cell painting assay
Related topics
Analytical techniques, Antibodies, Assays, Biopharmaceuticals, Disease research, Imaging, Immunology, Lab Automation, Microscopy, Proteomics, Stem Cells, Targets
Related organisations
Molecular Devices